French pharmaceutical company Sanofi, Swiss medical technology company Sensile Medical and Alphabet's life sciences arm Verily joined forces to develop a connected insulin patch pump.
Sanofi announced limited details about the alliance June 26 at the American Diabetes Association 78th Scientific Sessions in Orlando, Fla. Together, the three companies plan to create and commercialize a new generation of "all-in-one" pre-filled insulin patch pumps for patients with Type 2 diabetes.
The collaboration combines Sanofi's experience developing diabetes solutions, Sensile Medical's work developing micro-pump technologies and digital health expertise from Verily, formerly called Google Life Sciences.